Surf Wiki
Save to docs
general/designer-prodrugs

From Surf Wiki (app.surf) — the open knowledge base

Fenproporex

Stimulant drug used to treat obesity

Stimulant drug used to treat obesity

| Drugs.com =

Fenproporex (Perphoxene) (N-2-Cyanoethylamphetamine) (3-(1-phenylpropan-2-ylamino)propanenitrile) (3-[(1-Methyl-2-Phenylethyl)amino]propiononitrile) is a stimulant drug of the phenethylamine and amphetamine chemical classes that was developed in the 1960s. It is used as an appetite suppressant for the treatment of obesity.

Fenproporex produces amphetamine as a metabolite and was withdrawn in many countries following problems with abuse, but it is still prescribed in some countries. It is sometimes combined with benzodiazepines, antidepressants, and other compounds to create a version of the "rainbow diet pill".

Fenproporex has never been approved by the US Food and Drug Administration (FDA) for sale in the US due to lack of efficacy and safety data. However, in March 2009, the FDA warned consumers that it has been detected as an unlabeled component of diet pills available over the Internet. Fenproporex is designated a Schedule IV controlled substance in the US pursuant to the Controlled Substances Act.{{cite web |access-date = 2011-04-20 |url-status = dead |archive-url = https://web.archive.org/web/20111016184126/http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=49034c378cc5617a1af5088a76f6df73&rgn=div8&view=text&node=21%3A9.0.1.1.9.0.26.7&idno=21 |archive-date = 2011-10-16

Fenproporex is on the list of substances banned by the World Anti-Doping Agency, and any sportsperson testing positive for the substance faces a ban from competition.

References

References

  1. Anvisa. (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial". [[Diário Oficial da União]].
  2. (1991). "Drug dosage in renal insufficiency". Springer.
  3. Warembourg H, Jaillard J. Clinical experimentation with fenproporex in the treatment of obesity. Apropos of 40 cases. (French). ''Journal de la Faculte de médecine et de pharmacie de l'Universite de Lille''. 1968 Mar;13(3):Suppl:273-6.
  4. (October 1972). "Amphetamine concentrations in rat brain and human urine after fenproporex administration". European Journal of Pharmacology.
  5. (December 1993). "Metabolic Precursors to Amphetamine and Methamphetamine". Forensic Science Review.
  6. (March 2006). "Abusive prescription of psychostimulants: a study of two cases". Journal of Forensic Sciences.
  7. (March 2009). "Imported fenproporex-based diet pills from Brazil: a report of two cases". Journal of General Internal Medicine.
  8. (June 2009). "Imported compounded diet pill use among Brazilian women immigrants in the United States". Journal of Immigrant and Minority Health.
  9. (September 2012). "The return of rainbow diet pills". American Journal of Public Health.
  10. "Consumer Directed Questions and Answers about FDA's Initiative Against Contaminated Weight Loss Products". FDA/Center for Drug Evaluation and Research.
  11. [http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf The 2009 Prohibited List International Standard] {{webarchive. link. (February 3, 2009 . [[World Anti-Doping Agency]] (2009). Retrieved on 2009-08-18.)
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

designer-prodrugs nitriles norepinephrine-dopamine-releasing-agents substituted-amphetamines
Want to explore this topic further?

Ask Mako anything about Fenproporex — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report